ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 73 filers reported holding ATOSSA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $220,393 | -60.7% | 299,004 | -32.7% | 0.00% | – |
| Q2 2023 | $560,110 | +361.2% | 444,532 | +164.7% | 0.00% | – |
| Q1 2023 | $121,436 | -26.1% | 167,942 | -45.9% | 0.00% | – |
| Q4 2022 | $164,415 | -56.3% | 310,490 | -31.6% | 0.00% | – |
| Q3 2022 | $376,000 | -40.4% | 453,900 | -21.6% | 0.00% | – |
| Q2 2022 | $631,000 | -22.8% | 578,652 | -11.4% | 0.00% | – |
| Q1 2022 | $817,000 | -75.9% | 653,446 | -69.1% | 0.00% | – |
| Q4 2021 | $3,384,000 | -60.5% | 2,115,888 | -19.4% | 0.00% | -100.0% |
| Q3 2021 | $8,562,000 | -81.5% | 2,626,516 | -64.1% | 0.00% | -83.3% |
| Q2 2021 | $46,250,000 | +1477.4% | 7,317,977 | +426.6% | 0.01% | – |
| Q1 2021 | $2,932,000 | +793.9% | 1,389,556 | +301.7% | 0.00% | – |
| Q4 2020 | $328,000 | +164.5% | 345,900 | +577.4% | 0.00% | – |
| Q3 2020 | $124,000 | -54.2% | 51,061 | -28.4% | 0.00% | – |
| Q2 2020 | $271,000 | +411.3% | 71,354 | +195.3% | 0.00% | – |
| Q2 2018 | $53,000 | – | 24,162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 347,392 | $256 | 0.02% |
| XTX Topco Ltd | 167,427 | $123,310 | 0.02% |
| Laurion Capital Management LP | 2,225,800 | $1,639,302 | 0.01% |
| Virtu Financial LLC | 80,728 | $59 | 0.01% |
| Renaissance Technologies | 1,242,370 | $915 | 0.00% |
| LVM CAPITAL MANAGEMENT LTD/MI | 21,000 | $15 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 50,000 | $36,825 | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 133,591 | $98,390 | 0.00% |
| Caption Management, LLC | 75,000 | $55,238 | 0.00% |
| J. L. Bainbridge & Co., Inc. | 11,121 | $8,191 | 0.00% |